highlights on adjuvant alectinib in early alk positive nsclc: the alina study
Published 9 months ago • 1.9K plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
2:37
alectinib for the treatment of nsclc: an update on the alina trial
-
7:32
adjuvant alectinib vs. chemotherapy in early-stage alk nsclc: dr. amit kumar's analysis | crsf
-
1:13
the alina trial for alk nsclc
-
4:00
alectinib eclipses crizotnib for alk positive lung cancer
-
0:58
lung summary post esmo 2023 | oncology brothers | #2023 #cancer #esmo
-
0:59
is there still a need of chemotherapy? | oncology brothers | #2023 #cancer #esmo
-
1:42
dr. velcheti on potential of alectinib in frontline alk-positive nsclc
-
2:00
updated data from phase 2 study of alectinib in alk–positive non–small–cell lung cancer
-
0:57
neoadjuvant versus periop immunotherapy in nsclc | oncology brothers | #2023 #cancer #esmo
-
3:59
alectinib in alk-mutated nsclc
-
1:22
assessing the efficacy of alectinib versus crizotinib in alk-positive nsclc
-
1:50
promising phase iii results for alecensa in early-stage alk-positive lung cancer
-
1:56
alex: alectinib is the best first-line therapy available for alk-positive nsclc
-
1:46
is lorlatinib a better option for nsclc?
-
1:07
dr. massarelli on first-line alk nsclc treatment
-
1:37
dr. camidge on the alex trial in patients with alk nsclc
-
3:04
phase iii results for alectinib compared with crizotinib in alk metastatic nsclc
-
3:43
bfast: high dose alectinib for ret-positive nsclc